Specialized Care for Prostate Cancer
Most prostate cancer tumors are slow growing, but the disease is still the second leading cause of cancer deaths in men, behind lung cancer. That’s why it is important to find prostate cancer early, while it is easier to treat.
At Orlando Health Cancer Institute Urologic Cancer Center, our compassionate team of specialists use the latest diagnostic and treatment options for prostate cancer. Our multidisciplinary approach brings together the expertise of various fields to ensure you have a treatment plan tailored to your unique needs.
We offer next-level treatment options, including minimally invasive robotic surgery and precision-targeted radiation therapies designed to protect your quality of life. Our physicians are leading experts in their fields who are active in clinical trials and research studies, allowing them to offer our patients the best possible treatments.
Types of Prostate Cancer @accordionTitleTag.Name>
Prostate cancer, which forms in the small gland responsible for contributing fluid for semen, typically grows slowly. In fact, it is not uncommon for undiagnosed prostate cancer to be found in older men who have died of other causes. There are rare prostate cancers that are more aggressive. Types of prostate cancer include:
This is by far the most common type of prostate cancer. Adenocarcinomas occur throughout the body in glandular epithelial cells, which are found in the inside lining of organs, where they secrete fluids such as mucus and digestive juices. There are two primary subtypes of this cancer, also known as glandular prostate cancer:
- Acinar adenocarcinoma (conventional adenocarcinoma): This is the most common form, which starts at the back of the prostate, where it can be felt by your doctor during a digital rectal exam.
- Prostatic ductal adenocarcinoma (PDA): This rarer and more aggressive cancer may develop at the same time as acinar adenocarcinoma and is harder to detect.
This is a type of neuroendocrine tumor, which forms in cells related to the nervous system or in hormone-producing glands. Small cell carcinomas are rare and aggressive, representing less than 1 percent of prostate cancers. Often, there are no symptoms until the cancer has spread, making it difficult to detect in the early stages.
This rare cancer, also known as urothelial cancer, is found in the cells lining the urethra, the tube that carries urine outside the body. It usually begins in the bladder and spreads to the prostate.
Also known as soft-tissue prostate cancer, this rare cancer forms in the muscles and nerves of the prostate.
This very rare and aggressive cancer forms on the flat cells that cover the prostate gland. This cancer commonly spreads to bone, liver and lungs.
Risk Factors
We aren’t sure what causes prostate cancer. Tumors are created when there are mutations of DNA in cells in and around the prostate. These changes can affect the way cells operate, depriving them of the ability to repair themselves or to self-destruct when damage cannot be repaired. When those internal controls are lost, the damage can eventually lead to a tumor.
Among the biggest factors that increase your risk for prostate cancer is age. You risk begins rising rapidly after you turn 50, with 60 percent of prostate cancers found in men older than 65. The cancer is also more common in African American men and Caribbean men with African ancestry.
Research also shows that prostate cancer can run in families. Your risk is more than doubled if you have a brother or father with the disease. The risk is even higher if you have multiple relatives, particularly if they developed the disease at a young age.
Meet the Prostate Cancer Center Team
Our highly specialized team offers the most advanced care available for all types of prostate cancer. Our multidisciplinary approach brings together a team that includes a fellowship trained surgeon, urologist, radiation oncologist, medical oncologist, nutritionists, rehabilitation specialists and oncology nurse navigators.
Rectal Spacers
Our compassionate team offers the Rectal Spacer systems to protect your rectum during radiation treatment for prostate cancer. The Rectal Spacer lowers your risk of having harmful side effects from radiation therapy. By safeguarding healthy cells, the Rectal Spacer improves your quality of life.
Learn More About Prostate Cancer
-
Clinical Trials
Orlando Health Cancer Institute participates in clinical trials, testing and evaluating the latest therapies, treatments, screening and diagnostic tools for prostate cancer.
-
Diagnosis and Treatment
Orlando Health Cancer Institute’s multidisciplinary approach to treating prostate cancer offers you the best care possible.
-
Resources
At Orlando Health Cancer Institute, we strive to support patients and families in every way possible.
Navigate Your Health
Find a Cancer Physician
Find a Cancer Physician
Meet our doctors who specialize in the full range of cancer care. Our team of experts has experience in a variety of specialty areas. Together, we provide comprehensive evaluation, diagnosis and treatment options.
Learn MorePatient Portal
Patient Portal
If you are a patient at Orlando Health Cancer Institute, our free online patient portal provides an easy and secure way to manage your health information. Reach us from any location at a time that’s convenient for you.
Learn MoreVirtual Visit
Virtual Visit
Need to talk with a doctor, but don’t want to leave your home? Try our virtual visit (telehealth) option to connect with a physician from your phone, tablet or computer.
Learn More